(International HCO)
(International HCO)
(International HCO)
(Patient Organisation)
(Patient Organisation)
(International HCO)
Payments made to members of the public (payments made in 2023)
Britannia Pharmaceuticals Ltd (BPL) firmly believes transparency and honesty are essential in maintaining and upholding confidence in the pharmaceutical industry.
Below is the Methodological Note detailing the approach taken by BPL with regards to the collection and submission of all Transfers of Value (ToVs) to Patient Organisations, International Healthcare Organisations, and members of the public, as mandated in the Association of the British Pharmaceutical Industry (ABPI) Code of Practice.
Methodological Note
The types of ToVs included are:
For each of the above ToVs, the following are in place for each activity/service to be delivered:
Reporting period and dates
Disclosures are made annually in respect of each calendar year, for example, 1st January and 31st December 2023. ToVs are disclosed in the year the payments are made.
Currency
All payments disclosed are in the currency in which the payment was made in. i.e. Euros and Great British Pound (GBP)
Data collection
Financial data for each year was reviewed for ToVs made to Patient Organisations, International Healthcare Organisations, and members of the public. The data was cross referenced against records captured by the medical and commercial teams of completed engagements with Patient Organisations, International Healthcare Organisations, and members of the public.
No indirect ToVs have been made to Patient Organisations, International Healthcare Organisations and members of the public.
For members of the public, disclosures are aggregated into patients. Disclosure is not made against individuals. UK payments made to UK Healthcare Professionals and UK Healthcare Organisations can be found using this link.
Payments made to members of the public (payments made in 2023)